CASI Pharmaceuticals
CASI
#8912
Rank
A$0.12 B
Marketcap
$8.25
Share price
-3.96%
Change (1 day)
19.36%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -A$40.72 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$23.1 Million. In 2023 the company made an earning of -A$40.8 Million, an increase over its 2022 earnings that were of -A$57.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$40.72 Million-0.19%
2023 -A$40.8 Million-29.55%
2022 -A$57.91 Million4.43%
2021 -A$55.45 Million-24.56%
2020 -A$73.5 Million4.74%
2019 -A$70.18 Million65.13%
2018 -A$42.5 Million155.07%
2017 -A$16.67 Million13.93%
2016 -A$14.63 Million31.18%
2015 -A$11.15 Million-72.5%
2014 -A$40.54 Million356.62%
2013 -A$8.88 Million-60.55%
2012 -A$22.51 Million218.41%
2011 -A$7.07 Million0.74%
2010 -A$7.02 Million-32.54%
2009 -A$10.4 Million-66.98%
2008 -A$31.5 Million-14.22%
2007 -A$36.72 Million7.04%
2006 -A$34.3 Million27.95%
2005 -A$26.81 Million4.51%
2004 -A$25.65 Million-15.84%
2003 -A$30.48 Million-55.29%
2002 -A$68.17 Million-34.05%
2001 -A$0.11 Billion31.73%
2000 -A$78.47 Million31.56%
1999 -A$59.65 Million145.56%
1998 -A$24.29 Million76.4%
1997 -A$13.77 Million36.92%
1996 -A$10.06 Million